Genetic polymorphisms of adiponectin and tumor necrosis factor‐alpha and nonalcoholic fatty liver disease in Chinese people
暂无分享,去创建一个
V. Wong | F. Chan | J. Sung | W. So | H. Chan | S. Tsang | A. Chan | G. Wong | P. Choi | H. Chan | J. Y. Sung | A. Y. Hui | A. Tse | A. Hui | F. K.‐L. Chan | J. J. Sung
[1] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[2] Jun Yu,et al. Association of cytokine gene polymorphisms and liver fibrosis in chronic hepatitis B , 2008, Journal of gastroenterology and hepatology.
[3] H. J. de Silva,et al. How should we manage patients with non‐alcoholic fatty liver disease in 2007? , 2007, Journal of gastroenterology and hepatology.
[4] M. Taniai,et al. Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. , 2007, Journal of hepatology.
[5] F. Chan,et al. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non‐alcoholic fatty liver disease , 2006, Alimentary pharmacology & therapeutics.
[6] V. Wong,et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[7] R. Stratta,et al. Pancreas and islet transplantation in type 1 diabetes. , 2006, Diabetes care.
[8] F. Kronenberg,et al. The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in healthy Caucasians , 2006, European Journal of Human Genetics.
[9] Z. Canturk,et al. Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease , 2006, European journal of gastroenterology & hepatology.
[10] Lisa J. Martin,et al. Interactions between noncontiguous haplotypes in the adiponectin gene ACDC are associated with plasma adiponectin. , 2006, Diabetes.
[11] Tetsuji Sato,et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. , 2006, Annals of internal medicine.
[12] C. McClain,et al. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. , 2005, The Journal of pediatrics.
[13] I. Leclercq,et al. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. , 2005, Gastroenterology.
[14] G. Pacini,et al. Hypoadiponectinemia Predicts the Severity of Hepatic Fibrosis and Pancreatic Beta-Cell Dysfunction in Nondiabetic Nonobese Patients with Nonalcoholic Steatohepatitis , 2005, The American Journal of Gastroenterology.
[15] O. Uygur-Bayramiçli,et al. Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients? , 2005, World journal of gastroenterology.
[16] C. Zou,et al. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. , 2005, Endocrine journal.
[17] J. H. Lee,et al. Association of the 276G->T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans. , 2005, The American journal of clinical nutrition.
[18] D. Koop,et al. Steatohepatitis induced by intragastric overfeeding in mice , 2005, Hepatology.
[19] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.
[20] Y. Iwamoto,et al. Prevalence of non‐alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[21] S. Sanderson,et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.
[22] G. Marchesini,et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. , 2005, The Journal of clinical endocrinology and metabolism.
[23] M. Arca,et al. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤50 years) , 2005, Journal of Molecular Medicine.
[24] J. Sung,et al. Histological progression of non‐alcoholic fatty liver disease in Chinese patients , 2005, Alimentary pharmacology & therapeutics.
[25] L. Sechi,et al. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. , 2005, European journal of endocrinology.
[26] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[27] K. Lindor,et al. A Pilot Trial of Pentoxifylline in Nonalcoholic Steatohepatitis , 2004, The American Journal of Gastroenterology.
[28] H. Tilg,et al. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. , 2004, Biochemical and biophysical research communications.
[29] S. Sarin,et al. Beneficial Effects of Tumor Necrosis Factor-α Inhibition by Pentoxifylline on Clinical, Biochemical, and Metabolic Parameters of Patients with Nonalcoholic Steatohepatitis , 2004, American Journal of Gastroenterology.
[30] F. Chan,et al. Clinical and histological features of non‐alcoholic fatty liver disease in Hong Kong Chinese , 2004, Alimentary pharmacology & therapeutics.
[31] J. Kench,et al. Beyond insulin resistance in NASH: TNF‐α or adiponectin? , 2004, Hepatology.
[32] P. Hayashi,et al. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study , 2003, American Journal of Gastroenterology.
[33] G. Marchesini,et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.
[34] A. Moser,et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease , 2003, Hepatology.
[35] P. Scherer,et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. , 2002, Diabetes.
[36] L. N. Valenti,et al. Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease , 2002 .
[37] J. Crespo,et al. Gene expression of tumor necrosis factor α and TNF‐receptors, p55 and p75, in nonalcoholic steatohepatitis patients , 2001 .
[38] J. Chan,et al. Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. , 2001, The British journal of nutrition.
[39] K. Feingold,et al. TNF-alpha is not the cause of fatty liver disease in obese diabetic mice. , 2001, Nature medicine.
[40] M. Carrington,et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.
[41] G. Brandi,et al. Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.
[42] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[43] A. Kimura,et al. Polymorphism of the 5′‐flanking region of the human tumor necrosis factor (TNF)‐α gene in Japanese , 1998 .
[44] A. Kimura,et al. Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. , 1998, Tissue antigens.
[45] R. Hanson,et al. The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years , 1990, Hepatology.
[46] H. Nomura,et al. Prevalence of fatty liver in a general population of Okinawa, Japan. , 1988, Japanese journal of medicine.
[47] P. Christoffersen,et al. Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties. , 1977, Scandinavian journal of gastroenterology.